Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

404 trials

NCT06586177
Recruiting
Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies
Not applicable · Germany · 1 site
Registry update: 18 Sept 2025
NCT05124600
Recruiting
An Individualized-health eLibrary App for People With Multiple Sclerosis
Not applicable · United States · 1 site
Registry update: 24 Aug 2025
NCT05061953
Recruiting
Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
Not applicable · Canada · 2 sites
Registry update: 4 Nov 2026
NCT04694534
Recruiting
Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients
Not applicable · France · 6 sites
Registry update: 4 Sept 2025
2024-511686-11-00
Recruiting
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis
Phase 3 · Austria, Belgium, Germany, Estonia, Spain, France, Croatia, Italy, Latvia, Poland, Portugal, Romania, Slovakia · 25 sites
Registry update: 29 Sept 2026
Conflicting statuses (not updated in the registry for 1 month)
NCT04798651
Recruiting
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
Not applicable · France · 1 site
Registry update: 26 Oct 2026
NCT05003388
Recruiting
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for MS
Phase 1 · Greece, United States · 2 sites
Registry update: 20 Oct 2026
NCT05183152
Recruiting
Non-invasive BCI-controlled Assistive Devices
Not applicable · United States · 1 site
Registry update: 1 May 2026
NCT04699747
Recruiting
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
Phase 1 · United States · 1 site
Registry update: 7 Oct 2026
NCT07738978
Recruiting
Understanding and Enhancing Human Health and Movement
Not applicable · United States · 1 site
Registry update: 2 Nov 2026
NCT06663111
Recruiting
Rituximab and Ocrelizumab in Serum With Multiple Sclerosis
Not applicable · Norway · 1 site
Registry update: 29 Oct 2024
NCT05748015
Recruiting
Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis
Not applicable · Italy · 2 sites
Registry update: 17 Apr 2026
NCT04650321
Recruiting
Home Based Infusions for Ocrelizumab
Phase 4 · United States · 1 site
Registry update: 10 Jun 2021
NCT02912897
Recruiting
Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis
Phase 1 · France · 1 site
Registry update: 19 Feb 2025
NCT04876339
Recruiting
Sonification Techniques for Gait Training
Not applicable · Italy · 1 site
Registry update: 2 Jul 2026
NCT04604041
Recruiting
Investigation of Subclinical Markers of Multiple Sclerosis
Not applicable · Croatia · 1 site
Registry update: 2 Oct 2023
NCT05832515
Recruiting
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis
Phase 1 · Russia · 1 site
Registry update: 7 May 2024
NCT04561557
Recruiting
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
Early phase 1 · China · 1 site
Registry update: 30 Oct 2024
NCT04047628
Recruiting
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Phase 3 · United States · 23 sites
Registry update: 20 Oct 2026
NCT04334031
Recruiting
Deployment o the Multidisciplinary Prospective Cohort Imminent
Not applicable · France · 1 site
Registry update: 5 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.